Fact Sheet
Electronic Data Capture Recommender
Delivering measurable time savings and predictable ROI through accelerated Electronic Data Capture (EDC) design
Nov 06, 2026
Download

Clinical study start-up can be slowed by manual, repetitive and variable Electronic Data Capture (EDC) database design. This factsheet explains how IQVIA EDC Recommender helps pharma clinical development and data management teams accelerate protocol-to-database timelines by automating the initial EDC design while maintaining human oversight, review rigor and governance.

EDC Recommender reads the digital protocol, applies defined business rules and reuses approved components from a centralized EDC design library. By combining IQVIA or approved sponsor standards with historical study designs, it creates a consistent, traceable and protocol-specific starting point. The factsheet outlines how this standards-driven approach can deliver up to 62% time savings in initial EDC design and support four- to eight-week build timelines, depending on the selected model and level of customization.

Designed for pharma clinical leaders, heads of data management and study delivery teams, the asset shows how accelerated EDC design can reduce repetitive effort, improve predictability and limit downstream rework across UAT, data cleaning, SDTM mapping and analysis. It also compares accelerated, standard and custom delivery models, helping sponsors assess the right balance of speed, control, standardization and cost for their clinical portfolio.

Frequently asked questions: EDC design, study start-up and data management

IQVIA EDC Recommender automates the initial, variable stage of EDC database design by reading the digital protocol, applying defined business rules and reusing approved design components. Study teams retain control of review, governance and decision-making, while automation reduces repetitive configuration work. Depending on standards and customization, the approach can support four- to eight-week EDC build timelines.
EDC Recommender delivers up to 62% time savings in generating the initial EDC design. This can help teams move more quickly from protocol finalization to EDC database setup while focusing review effort on protocol-specific elements rather than repeatedly reviewing established content.
Consistent, standards-driven EDC designs help address variability at the source. By applying approved components and business rules from the outset, EDC Recommender can reduce issues that otherwise emerge during UAT, data cleaning, SDTM mapping and analysis, helping limit avoidable review cycles, delays and rework.
Yes. The centralized EDC design library can incorporate approved sponsor standards as well as IQVIA standards and historical study designs. The standard and custom delivery models provide options for sponsors that need to use their own approved standards, integrations or additional UAT cycles.
EDC Recommender applies centrally defined standards and business rules across designs, creating a repeatable and traceable starting point for each study. It also draws on historical study designs so prior learnings can be applied systematically, reducing variation and improving predictability across programs and portfolios.
The accelerated model uses IQVIA standards, requires minimal sponsor involvement and supports a four-week build timeline. The standard model uses IQVIA or approved sponsor standards, includes one sponsor UAT round and supports an eight-week timeline. The custom model supports sponsor-specific standards, broader integrations and multiple UAT cycles, with timing reflecting the added complexity.
By automating the generation of visits, forms, fields, code lists and edit checks, EDC Recommender reduces repetitive manual effort across data management, clinical programming and review teams. Faster design, improved resource utilization and less downstream rework translate time savings into measurable operational and financial value.
No. EDC Recommender is a virtual assistant that removes repetitive and variable design work; it does not remove human oversight. Clinical and data management teams remain responsible for governance, review and key decisions, allowing expert effort to focus on protocol-specific requirements and higher-value activities.

Related solutions